These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17241408

  • 1. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes.
    Carruthers J, Carruthers A.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S10-7. PubMed ID: 17241408
    [Abstract] [Full Text] [Related]

  • 2. Novel topical BoNTA (CosmeTox, toxin type A) cream used to treat hyperfunctional wrinkles of the face, mouth, and neck.
    Chajchir I, Modi P, Chajchir A.
    Aesthetic Plast Surg; 2008 Sep; 32(5):715-22; discussion 723. PubMed ID: 18491179
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S, Cox SE, Finn JC, Werschler WP, Kowalski JW.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [Abstract] [Full Text] [Related]

  • 5. A single-center dose-comparison study of botulinum neurotoxin type A in females with upper facial rhytids: assessing patients' perception of treatment outcomes.
    Carruthers A, Carruthers J.
    J Drugs Dermatol; 2009 Oct; 8(10):924-9. PubMed ID: 19852121
    [Abstract] [Full Text] [Related]

  • 6. A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: safety and efficacy.
    Carruthers A, Carruthers J.
    J Am Acad Dermatol; 2009 Jun; 60(6):972-9. PubMed ID: 19467368
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group.
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 9. Patient-reported outcomes with botulinum neurotoxin type A.
    Carruthers A, Carruthers J.
    J Cosmet Laser Ther; 2007 Apr; 9 Suppl 1():32-7. PubMed ID: 17885884
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ, Glaser DA, Eadie N, Daggett S, Kowalski JW, Lai PY, North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group.
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [Abstract] [Full Text] [Related]

  • 11. Different formulations of botulinum toxin type A have different migration characteristics: a double-blind, randomized study.
    Cliff SH, Judodihardjo H, Eltringham E.
    J Cosmet Dermatol; 2008 Mar; 7(1):50-4. PubMed ID: 18254812
    [Abstract] [Full Text] [Related]

  • 12. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids.
    de Boulle K.
    J Cosmet Laser Ther; 2008 Jun; 10(2):87-92. PubMed ID: 18569261
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B, Rzany BJ, Grover R.
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM, Schim JD, Chippendale TJ.
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [Abstract] [Full Text] [Related]

  • 15. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]

  • 16. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A, Carruthers J.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [Abstract] [Full Text] [Related]

  • 17. EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial.
    Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MM, Sanjari MS, Naseripour M.
    Ann Plast Surg; 2008 Apr; 60(4):353-6. PubMed ID: 18362558
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W.
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [Abstract] [Full Text] [Related]

  • 19. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A, Carruthers J, Cohen J.
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin A adjunctive use in manual chemabrasion: controlled long-term study for treatment of upper perioral vertical wrinkles.
    Kadunc BV, Trindade DE Almeida AR, Vanti AA, DI Chiacchio N.
    Dermatol Surg; 2007 Sep; 33(9):1066-72; discussion 1072. PubMed ID: 17760597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.